Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt 1mg, Wegovy is a titration step on the way to its maintenance dose, not a long-term landing point. Most people reach 1mg semaglutide after roughly eight weeks and continue titrating upward, so the weight loss at this stage reflects early progress rather than the full picture the overall Wegovy programme can deliver. These are prescription-only medicines; a GPhC-registered prescriber decides whether treatment is clinically appropriate for you, and your dose schedule is set by them, not by any chart online.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The dose schedule for Wegovy runs from 0.25mg to a standard maintenance dose of 2.4mg, with steps at 0.5mg, 1mg and 1.7mg along the way. Each step lasts around four weeks, so 1mg is typically where you are in weeks nine to twelve of treatment. By that point, appetite suppression is building and most people have already lost some weight, but the clinical trial evidence that makes headlines refers to what happens over 68 weeks at the 2.4mg maintenance dose.
In STEP 1, published in the New England Journal of Medicine, adults on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks alongside lifestyle changes. At the 1mg mark you are still months away from that outcome. Some people feel the dose working clearly at this stage; others notice modest changes and find things accelerate once their prescriber moves them up. Both are normal, and neither is a signal to stop.
The 2.4mg maintenance dose is where the trial results were recorded, and the 1.7mg step sits just before it. Understanding where 1mg sits on that path matters before you make any decisions about whether treatment is delivering what you hoped.
Private treatment with Wegovy is priced per four-week pen, and that price shifts as doses increase. Since Eli Lilly raised its Mounjaro list price in September 2025, the UK private market for GLP-1 weight-loss medicines has been re-pricing broadly; for context, private semaglutide costs typically range somewhere in the region of £149 to £375 per month depending on the dose and the provider, though those figures move and vary, treat them as indicative rather than fixed. The current Wegovy pricing picture is worth reading if cost is the central question for you.
What matters is what that number actually includes. Headline prices sometimes cover the pen alone. Separately, you may find consultation fees, prescription charges, delivery costs and follow-up reviews sitting outside the figure quoted upfront. That adds up, particularly on a medicine that requires clinical review before each new pen is issued. A question worth asking any provider: is every repeat order re-reviewed by a prescriber, or is it automated once you're set up?
If you are based in Scotland, private Wegovy pricing in Scotland broadly follows the same market, though NHS access routes differ between nations.
We are not the cheapest option. That is a choice, not an oversight. The single price at nume covers the clinical consultation, the prescription, the medicine itself, and free next-working-day delivery, your pen arrives in a plain, unbranded DPD box with a tracking link sent to your phone, and the KwikPen inside is refrigerated during transit. There are no subscription commitments. Every repeat is re-reviewed by a GPhC-registered Independent Prescriber before it is issued; a real clinician reads your update, not software.
Our pharmacy holds GPhC premises registration 9012878, which you can verify on the GPhC register directly. Medicines come through the licensed UK supply chain, with Novo Nordisk as the manufacturer. Aftercare is available seven days a week. There are no discount codes, no promotional pricing and no vouchers, not because we forgot, but because running them on a prescription medicine would be the wrong thing to do. What we focus on instead is the service around it.
You can read more about the team behind nume, including our approach to clinical oversight, or explore the treatment options we support more broadly.
For a prescription-only medicine, the cheapest listing answers the wrong question. The MHRA has warned publicly about fake weight-loss pens circulating through social media and unverified sellers, in 2025, around 20 million doses of illegally traded weight-loss medicines worth approximately £45m were seized, and the first UK site manufacturing counterfeit tirzepatide pens was raided. Semaglutide pens are among the most counterfeited medicines in the UK right now. A seller offering them at a noticeably low price with no visible clinical process attached is a red flag worth taking seriously.
The right question is whether the provider is GPhC-registered, whether the medicines come from the licensed supply chain, and whether a qualified prescriber is making decisions about your care. If you want to check any online pharmacy yourself, the GPhC register is the place to do it. Suspect sellers can be reported via the MHRA's Yellow Card scheme.
If you are considering Wegovy and want to understand the full results picture before deciding, the week-by-week weight loss on Wegovy page covers what the data shows at different points in treatment. When you are ready to take the next step, check your eligibility through a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.